openPR Logo
Press release

Transdermal and Transmucosal Drug Delivery Systems Market Regional Analysis by 2025

03-26-2018 06:27 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

Transdermal and Transmucosal Drug Delivery Systems Market

Global Transdermal and Transmucosal Drug Delivery Systems Market: Snapshot

Transdermal and transmucosal drug delivery systems as alternative drug delivery routes have gained traction in clinical practices over the past few decades. The need for these systems is driven by the growing demand for controlled drug delivery to achieve a number of clinical objectives. These delivery systems have been found to be useful for improving pharmacological response of drugs and their efficacy. Marked difficulty in developing new chemical entities and the considerable time gap for their approval have persuaded various pharmaceutical companies to focus on improving the therapeutic outcomes of the already approved drugs. Alternative delivery systems are developed to achieve this objective and increase patient compliance. In recent years, transdermal drug delivery system (TDDS) has been found to be promising for developing novel drug delivery systems.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=123

A transdermal drug delivery system also known as transdermal patches offer several advantages over common types of drug delivery systems such as topical, oral, intravenous, and intramuscular. The mechanism includes controlled delivery drugs into systemic circulation through the skin and into the bloodstream of patients at a predetermined rate and for a long duration without being affected by intra and inter patient variations. Key advantages comprise overcoming the limitation of first-pass metabolism through liver and maintaining a steady plasma level of drugs administered. The development of TDDS helps in bringing the release of intended medications at zero order rate. As a result, they are preferred for prophylactic therapies in various chronic conditions. However, the adoption of TDDS in the mainstream medication delivery seems to be crippled by several constraints. Some of the notable limitations of TDDS include the inability of the system to deliver ionic drugs and drugs cannot be delivered in a pulsatile manner. Further feasibility studies spanning multiple disciplines are needed to demonstrate the efficacy and viability of transdermal and transmucosal drug delivery systems, including patient comfort and economy of these systems.

Global Transdermal and Transmucosal Drug Delivery Systems Market: Brief Overview

Transdermal drug delivery systems (TDDS) generally known as patches, are the systems use intact skin, as a mean of administering drug into the circulation system of the body. A transdermal patch is a free separate dose form which when applied on the skin, transports the medication at a precise and organized rate. The first transdermal system was approved by the FDA in 1979 for the treatment of vomiting and nausea. There are several benefits associated with transdermal and transmucosal drug delivery systems such as they evade first pass effect, decrease multiple dosage, avoid chemically unfriendly GI environment, improve patient compliance, permit use of drugs with short shelf life, provide a controlled release of very potent drugs and drug input can be easily interrupted when toxicity occurs.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=123

This industry research report is a brief review of the growth trail in terms of current, historical, and future scenarios of the global transdermal and transmucosal drug delivery systems market. It offers an evaluation of the aspects that are expected to influence the development of the market and the primary trends have also been specified in the research study. The research study also offers a broad lookout on the vendor landscape of the market through Porter’s five forces analysis. The research publication provides references of mergers and acquisitions, the research and development activities, specifics on licensing and collaborations. The report probes into the strategies related to marketing, shares, and product portfolio of the key participants in the global transdermal and transmucosal drug delivery systems market.

Global Transdermal and Transmucosal Drug Delivery Systems Market: Emerging Trends

The transdermal and transmucosal drug delivery systems market is exhibiting a commendable growth owing to the high incidence rate of chronic diseases such as diabetes and hypertension. Moreover, ghoulish lifestyle practices, extreme alcohol consumption, and the consumption of drugs such as amphetamines and cocaine among people are the chief factors triggering heart disease, further augmenting the growth of transdermal and transmucosal drug delivery systems market. However, an upsurge in overall healthcare expenditure, severe regulatory policies, and high costs of clinical trials are some of the factors are likely to impede the growth of TDDS system. Presently, transdermal and transmucosal drug delivery systems market is an extremely fragmented and reputed market owing to the participation of many recognized as well as emerging players in the industry.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/transdermal-transmucosal-drug-delivery-systems-market

Global Transdermal and Transmucosal Drug Delivery Systems Market: Regional Analysis

Geographically, North America is the leading market for transdermal and transmucosal drug delivery systems owing to the high incidence rate of cardiac diseases along with the increasing base of brain disorder patients. A sizeable number of such patients are expected to drive the market growth for transdermal and transmucosal drug delivery systems. However, other regions such as South East Asia, Middle East and Latin America are also projected to be the prospective markets in the future for vendors.

Global Transdermal and Transmucosal Drug Delivery Systems Market: Vendor Landscape

Some of key participants in the market are Medipatch, Inc., Aveva Drug Delivery Systems, 3M Pharmaceuticals, DURECT Corporation, ALZA Corporation, and TEVA Pharmaceutical Industries Ltd.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal and Transmucosal Drug Delivery Systems Market Regional Analysis by 2025 here

News-ID: 991255 • Views: 179

More Releases from TMR Research

Dermal Filler Market Booming Demand Leading To Exponential CAGR Growth By 2025 | …
Global Derma Filler Market: Snapshot Derma fillers are also referred to as soft-tissue fillers or injectable. They are known for filling up an area under a particular skin spot or patch. Some fillers are made using natural ingredients whereas some are manufactured using synthetic products. All types of derma fillers, whether synthetic or natural work on improving the appearance and presentation of the aging skin in many ways such as they
Big Data In Healthcare Market Players, Opportunities and Growth Scope 2017 COVID …
Global Big Data in Healthcare Market: Overview The big data in healthcare market is believed to be the future and game-changer of the healthcare sector with high adoption amongst medical professionals, government bodies, and even patients. The global market is currently trending on the back of innovative headways, higher incentives reserved for medication, and big data adoption in healthcare. The segmentation study of the global big data in healthcare market could
Dental Suture Market Recent Trends, Development,Growth& Forecast 2017-2025
Global Dental Sutures Market: Snapshot Despite the vast rise in the number of wound closure practices, suturing continue to remain one of the most preferred across ones across a number of surgical practices, with density being no exception. Dentists across the globe continue to use appropriate sutures to secure surgical flaps and close wounds to promote healing. As the global market for dentistry expands at a massive pace across the globe,
Dental Software Market Demand, Supply, Growth Factors, Latest Rising Trend And F …
Global Dental Software Market: Snapshot The world of dentistry continued to move ahead at a massive pace and is witnessing an increasing influx of advanced technologies. From witnessing the use of electric handpieces as replacement for speed belt driven tools to using tiny yet high-precision digital cameras to capture dental impressions to employing laser instead of scalpels, conventional dental practice has moved miles ahead in the present day scenario. Digital technologies

All 5 Releases


More Releases for Transdermal

Fentanyl Transdermal Patches Market – Comprehensive Survey 2025
This research study is one of the most detailed and accurate ones that solely focus on the global Fentanyl Transdermal Patches market. It sheds light on critical factors that impact the growth of the global Fentanyl Transdermal Patches market on several fronts. Market participants can use the report to gain sound understanding of the competitive landscape and strategies adopted by leading players of the global Fentanyl Transdermal Patches market. The
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Transdermal Patch 2. Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch 3. Why There Exist Need for Transdermal Patches? 4. Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Transdermal Patch Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch Why There Exist Need for Transdermal Patches? Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of Transdermal Patch 4.3
Transdermal Drug Delivery Market & Clinical Pipeline Insight
Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through the layers of